Tagrisso 80 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB26FX4EL
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,663
Award facts
- Contract value 100% obligated
- $10,662.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $10,662.57. This non-set-aside award, issued on October 31, 2025, is scheduled for completion by November 24, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Tagrisso is a prescription oncology medication used in the treatment of certain lung cancers, reflecting the DLA's ongoing pharmaceutical procurement requirements for military and federal healthcare systems.
This delivery order represents a task order issued against AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying a comprehensive range of medications and medical supplies across multiple therapeutic domains to support military healthcare programs globally. The company's capacity to fulfill this specialized oncology pharmaceutical request demonstrates its role as a key provider within the federal supply chain for the Department of Defense health systems.
Quick answers
Who was awarded contract SPE2DB26FX4EL?
SPE2DB26FX4EL was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FX4EL worth?
The government has obligated $10,663 on SPE2DB26FX4EL.
Is contract SPE2DB26FX4EL an order under another contract?
Yes. SPE2DB26FX4EL is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4EL competed?
The extent of competition for SPE2DB26FX4EL was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award